Pharmacy

Your Article Summary

See Latest Articles

Pharmacological efficacy and safety profile of taranabant in preclinical species
Drug Development Research, 07/16/09

Fong TM et al. - The highly selective nature of taranabant is consistent with its generally favorable preclinical safety profile.

Related Articles

See all related articles

Systematic review and meta-analysis on the adverse events of rimonabant treatment: Considerations for its potential use in hepatology
BMC Gastroenterology, 10/12/09    Relevance Score: 85%

Efficacy and Safety of Ezetimibe Plus Orlistat or Rimonabant in Statin-Intolerant Nondiabetic Overweight/Obese Patients With Dyslipidemia
Journal of Cardiovascular Pharmacology and Therapeutics, 11/12/09    Relevance Score: 83%

The CB1 antagonist rimonabant (SR141716) blocks cue-induced reinstatement of cocaine seeking and other context and extinction phenomena predictive of relapse
Drug and Alcohol Dependence, 10/26/09    Relevance Score: 80%

Today in Major Studies...keeping you current

Receive free subspecialty "5-minute updates" via email

Evaluation of Treatment Satisfaction in Children with Allergic Disease Treated with an Antihistamine: An International, Non-Interventional, Retrospective Study
Clinical Drug Investigation, 12/11/09

Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America
Sanofi-aventis, 12/10/09

Allos Therapeutics' FOLOTYN Shows Activity in a Dose Finding Phase 1 Study of Relapsed or Refractory Cutaneous T-Cell Lymphoma
Allos Therapeutics, 12/09/09

 See all of Major Studies

Today in Other Drugs...keeping you current

Receive free subspecialty "5-minute updates" via email

Dienogest: a new therapeutic agent for the treatment of endometriosis *TEST*
Women's Health, 12/17/09

Investigational drugs for allergic rhinitis
Expert Opinion on Investigational Drugs, 12/17/09

Predicting short term response to anti-inflammatory therapy in young children with asthma
Current Medical Research and Opinion, 12/17/09

 See all of Other Drugs